Table 1.
Measurement and group |
Before ischemia |
End of ischemia |
After Reperfusion |
||||
---|---|---|---|---|---|---|---|
l h | 3 h | 6 h | 12 h | 24 h | |||
ALT | |||||||
CT | 32 ± 4 | 33 ± 3 | 4,961 ± 798 | 6,576 ± 1,007 | 9,332 ± 1,128 | 13,563 ± 1,379 | 12,680 ± 1,451 |
LA | 17 ± 3 | 21 ± 2 | 1,610 ± 373* | 2,277 ± 503* | 2,732 ± 601* | 3,214 ± 661* | 2,378 ± 517* |
FK | 19 ± 6 | 26 ± 15 | 2,202 ± 758* | 2,814 ± 1139* | 3,766 ± 1,568* | 3,410 ± 1,521* | 2,789 ± 1,388* |
LDH | |||||||
CT | 81 ± 16 | 173 ± 27 | 3,385 ± 474 | 3,128 ± 479 | 2,906 ± 559 | 3,046 ± 634 | 1,441 ± 216 |
LA | 72 ± 12 | 185 ± 52 | 1,391 ± 355* | 1,250 ± 304* | 968 ± 254* | 693 ± 186* | 261 ± 49* |
FK | 121 ± 57 | 165 ± 99 | 1,991 ± 704 | 1,628 ± 623* | 1,142 ± 314* | 603 ± 192* | 343 ± 128* |
TBA | |||||||
CT | 0.3 ± 0.3 | 29.9 ± 6.3 | 48.5 ± 11.7 | 100.2 ± 11.0 | 133.8 ± 11.8 | 124.3 ± 13.1 | 175.4 ± 39.0 |
LA | — | — | 70.6 ± 19.4 | 87.6 ± 25.1 | 58.0 ± 35.2* | 41.2 ± 22.4* | 20.2 ± 6.7* |
FK | — | — | 49.6 ± 10.8 | 83.6 ± 23.2 | 68.8 ± 24.4* | 53.2 ± 13.4* | 53.4 ± 24.5* |
HA | |||||||
CT | 16.7 ± 6.5 | 348.9 ± 68.1 | 78.1 ± 27.5 | 61.4 ± 17.4 | 82.4 ± 30.9 | 112.6 ± 23.8 | 515.3 ± 167.5 |
LA | 9.4 ± 4.3 | 371.2 ± 113.5 | 28.8 ± 6.5 | 42.3 ± 22.7 | 39.4 ± 13.6 | 36.2 ± 10.3* | 201.1 ± 50.0 |
FK | 12.2 ± 7.5 | 261.0 ± 84.8 | 22.8 ± 13.1 | 74.0 ± 33.2 | 55.9 ± 26.8 | 47.1 ± 13.4* | 188.4 ± 60.2* |
ALT, alanine aminotransferase; CT, untreated control (n = 10); FK, group treated with FK409 (n = 5); HA, hyaluronic acid; LA, group tested with L-arginine (n = 5); LDH, lactate dehydrogenase; TBA, total bile acid.
p < 0.05 versus group CT. Data are expressed as mean ± SEM.